These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9519726)

  • 1. Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM.
    Chowdhury TA; Dyer PH; Kumar S; Gibson SP; Rowe BR; Davies SJ; Marshall SM; Morris PJ; Gill GV; Feeney S; Maxwell P; Savage D; Boulton AJ; Todd JA; Dunger D; Barnett AH; Bain SC
    Diabetes; 1998 Feb; 47(2):278-80. PubMed ID: 9519726
    [No Abstract]   [Full Text] [Related]  

  • 2. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
    Araki S; Moczulski DK; Hanna L; Scott LJ; Warram JH; Krolewski AS
    Diabetes; 2000 Dec; 49(12):2190-5. PubMed ID: 11118024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
    Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
    Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotypes and risk of diabetic nephropathy.
    Onuma T; Laffel LM; Angelico MC; Krolewski AS
    J Am Soc Nephrol; 1996 Jul; 7(7):1075-8. PubMed ID: 8829124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
    Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
    Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein E epsilon 2 allele and diabetic nephropathy].
    Eto M; Saito M; Kaku K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():807-11. PubMed ID: 11347178
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
    Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
    Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM.
    Fogarty DG; Harron JC; Hughes AE; Nevin NC; Doherty CC; Maxwell AP
    Diabetes; 1996 Sep; 45(9):1204-8. PubMed ID: 8772723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
    Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
    Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
    Werle E; Fiehn W; Hasslacher C
    Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio.
    Ururahy MA; de Souza KS; Oliveira YM; Loureiro MB; da Silva HP; Freire-Neto FP; Bezerra JF; Luchessi AD; Doi SQ; Hirata RD; Almeida Md; Arrais RF; Hirata MH; de Rezende AA
    Diabetes Metab Res Rev; 2015 Jul; 31(5):500-6. PubMed ID: 25384728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
    Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
    J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype is a determinant of low-density lipoprotein cholesterol and of its response to a low-cholesterol diet in Type 1 diabetic patients with elevated urinary albumin excretion.
    Blaauwwiekel EE; Beusekamp BJ; Sluiter WJ; Hoogenberg K; Dullaart RP
    Diabet Med; 1998 Dec; 15(12):1031-5. PubMed ID: 9868977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
    Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
    Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
    Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
    Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
    Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
    Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.
    Tarnow L; Stehouwer CD; Emeis JJ; Poirier O; Cambien F; Hansen BV; Parving HH
    Nephrol Dial Transplant; 2000 May; 15(5):625-30. PubMed ID: 10809802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta mice.
    Aoki T; Kaneko S; Tanimoto M; Gohda T; Hagiwara S; Murakoshi M; Ishikawa Y; Furukawa M; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(1):127-36. PubMed ID: 21725918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.